138 related articles for article (PubMed ID: 9614620)
21. The apolipoprotein epsilon2 allele and the severity of coronary artery disease in Type 2 diabetic patients.
Kalix B; Meynet MC; Garin MC; James RW
Diabet Med; 2001 Jun; 18(6):445-50. PubMed ID: 11472462
[TBL] [Abstract][Full Text] [Related]
22. [The relationship of Apo E2 and renal insufficiency lipid levels in NIDDM].
Xiang G; Xia B; He Y
Zhonghua Yi Xue Za Zhi; 1999 May; 79(5):339-41. PubMed ID: 11715472
[TBL] [Abstract][Full Text] [Related]
23. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
[TBL] [Abstract][Full Text] [Related]
24. Skeletal muscle lipoprotein-lipase activity in insulin-dependent diabetic patients with and without albuminuria.
Hansen PM; Jensen T; Egeberg J; Lithell H; Kofoed-Enevoldsen A; Deckert T
J Diabetes Complications; 1997; 11(4):230-5. PubMed ID: 9201600
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein E polymorphism is associated with plasma cholesterol response in a 7-day hospitalization study for metabolic and dietary control in NIDDM.
Murakami K; Shimizu M; Yamada N; Ishibashi S; Shimano H; Yazaki Y; Akanuma Y
Diabetes Care; 1993 Apr; 16(4):564-9. PubMed ID: 8462379
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for retardation of renal function in IDDM and NIDDM with nephropathy.
Hara S; Arizono K; Ubara Y; Morita T; Suzuki Y; Ogura Y; Hagura R; Akanuma Y
J Diabet Complications; 1991; 5(2-3):131-3. PubMed ID: 1770020
[TBL] [Abstract][Full Text] [Related]
27. Association of apo E polymorphism with plasma lipid levels in a multiethnic elderly population.
Pablos-Méndez A; Mayeux R; Ngai C; Shea S; Berglund L
Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3534-41. PubMed ID: 9437203
[TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein E phenotypes and plasma lipids in diabetic children and adolescents.
Salo MK; Rantanen R; Huupponen T; Lehtimäki T; Jokela H
Eur J Pediatr; 1993 Jul; 152(7):564-8. PubMed ID: 8354314
[TBL] [Abstract][Full Text] [Related]
29. Apolipoprotein E genotypes and risk of diabetic nephropathy.
Onuma T; Laffel LM; Angelico MC; Krolewski AS
J Am Soc Nephrol; 1996 Jul; 7(7):1075-8. PubMed ID: 8829124
[TBL] [Abstract][Full Text] [Related]
30. Relationship between Apolipoprotein E polymorphism and nephropathy in type-2 diabetic patients.
Leiva E; Mujica V; Elematore I; Orrego R; Díaz G; Prieto M; Arredondo M
Diabetes Res Clin Pract; 2007 Nov; 78(2):196-201. PubMed ID: 17481771
[TBL] [Abstract][Full Text] [Related]
31. Apolipoprotein-E gene polymorphism and lipid profiles in Alzheimer's disease.
Isbir T; Agaçhan B; Yilmaz H; Aydin M; Kara I; Eker E; Eker D
Am J Alzheimers Dis Other Demen; 2001; 16(2):77-81. PubMed ID: 11302074
[TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein E genotypes and metabolic risk factors for coronary heart disease in middle-aged women.
Cubrilo-Turek M; Stavljenić-Rukavina A; Sertić J; Zrinski R; Turek S; Grgac G; Ljubojević N
Coll Antropol; 1998 Jun; 22(1):149-55. PubMed ID: 10097431
[TBL] [Abstract][Full Text] [Related]
33. Genetic influences on age-related change in total cholesterol, low density lipoprotein-cholesterol, and triglyceride levels: longitudinal apolipoprotein E genotype effects.
Jarvik GP; Austin MA; Fabsitz RR; Auwerx J; Reed T; Christian JC; Deeb S
Genet Epidemiol; 1994; 11(4):375-84. PubMed ID: 7813899
[TBL] [Abstract][Full Text] [Related]
34. Phenotypes of apolipoprotein E and abnormalities in lipid metabolism in patients with non-insulin-dependent diabetes mellitus.
Imari Y; Koga S; Ibayashi H
Metabolism; 1988 Dec; 37(12):1134-8. PubMed ID: 3193900
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients.
Eto M; Saito M; Okada M; Kume Y; Kawasaki F; Matsuda M; Yoneda M; Matsuki M; Takigami S; Kaku K
Am J Kidney Dis; 2002 Aug; 40(2):243-51. PubMed ID: 12148096
[TBL] [Abstract][Full Text] [Related]
36. Association of polymorphisms in IL6 gene promoter region with type 1 diabetes and increased albumin-to-creatinine ratio.
Ururahy MA; de Souza KS; Oliveira YM; Loureiro MB; da Silva HP; Freire-Neto FP; Bezerra JF; Luchessi AD; Doi SQ; Hirata RD; Almeida Md; Arrais RF; Hirata MH; de Rezende AA
Diabetes Metab Res Rev; 2015 Jul; 31(5):500-6. PubMed ID: 25384728
[TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein E polymorphism and lipoprotein compositions in patients with Behçet's disease.
Tursen U; Eskandari G; Kaya TI; Tamer L; Ikizoglu G; Atik U
Int J Dermatol; 2004 Dec; 43(12):900-3. PubMed ID: 15569012
[TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein levels in normolipidemic non-insulin-dependent diabetes mellitus.
Horng YC; Wei JS; Chang RS; Huang HS; Huang MJ; Huang BY
J Formos Med Assoc; 1992 Jun; 91(6):590-4. PubMed ID: 1358344
[TBL] [Abstract][Full Text] [Related]
39. Apovarepsilon(4) allele increases the risk for exercise-induced silent myocardial ischemia in non-insulin-dependent diabetes mellitus.
Guangda X; Bangshun X; Xiujian L; Yangzhong H
Atherosclerosis; 1999 Dec; 147(2):293-6. PubMed ID: 10559515
[TBL] [Abstract][Full Text] [Related]
40. [Study on apoE gene polymorphism in Chinese type II b hyperlipidemia].
Zhang X; Bai H; Liu B; Fan P; Zhang R; Xu Y; Yao J; Zhu H
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Jun; 32(2):179-82. PubMed ID: 12600078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
